GSA Capital Partners’s Apyx Medical APYX Stock Holding History

GSA Capital Partners’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-41,593	Closed	-$209K	–	1476
2023 Q2	$209K	Sell	41,593 -171,549	-80%	-$869K	0.02%	1239
2023 Q1	$614K	Buy	213,142 +121,454	+132%	+$355K	0.06%	584
2022 Q4	$215K	Buy	+91,688	New	+$280K	0.03%	1141
2020 Q4	–	Sell	-26,772	Closed	-$126K	–	1186
2020 Q3	$126K	Buy	+26,772	New	+$133K	0.02%	1101
2019 Q2	–	Sell	-18,800	Closed	-$119K	–	1422
2019 Q1	$119K	Buy	18,800 +100	+0.5%	+$774	0.01%	1315
2018 Q4	$121K	Buy	18,700 +8,500	+83%	+$51.5K	0.01%	1196
2018 Q3	$72K	Buy	+10,200	New	+$56.7K	﹤0.01%	1578

Other funds holding APYX

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return